AditiDhirMD

Pediatric Hematology & Oncology • Miami, FL

Pediatric Hematologic Oncology

Assistant Professor

Join to view full profile

Dr. Dhir is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dhir's full profile

Already have an account?

Office
1601 NW 12th Ave
Fl 5
Miami, FL 33136
Phone+1 305-585-5635

Education & Training

University of Alabama Medical CenterFellowship, Pediatric Hematology/Oncology, 2017 - 2020
Cleveland Clinic FoundationResidency, Pediatrics, 2014 - 2017
Lady Hardinge Medical CollegeClass of 2013

Certifications & Licensure

FL State Medical License 2020 - 2026
AL State Medical License 2017 - 2020
OH State Medical License 2014 - 2017
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Fou...
Aditi Dhir, Masanori Hayashi, Avery Bodlak, Javier Oesterheld, David M Loeb
Clinical Cancer Research. 2024-12-02
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board.
Ajay Gupta, Matthew S Dietz, Richard F Riedel, Aditi Dhir, Scott C Borinstein
Cancer. 2024-12-01
Rarerearrangement in a case of de novo pediatric AML and review of cases.
Mathilde Hainaut, Valishti Pundit, C Federico Moral-Ortega, Julio Barredo, David Crawford
Leukemia & Lymphoma. 2024-09-20

Lectures

An Epigenetic Screen Identifies PRMT5 As a Target for Inhibition of FLT3-ITD AML Cell Growth in Combination with Tyrosine Kinase Inhibitors
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

University of Miami Miller School of Medicine Selected for National NF2 Tumor Clinical TrialJune 1st, 2022